Gefitinib does not improve survival when combined with paclitaxel and carboplatin chemotherapy in people with advanced non-small-cell lung cancer☆, ☆, ☆☆Abstracted from: Herbst RS, Giaccone G, Schiller JH et al. Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial – INTACT 2. J Clin Oncol 2004;22:785–94.

• 期刊名称Cancer Treatment Reviews
• 作者EVANS, W
• 卷第30卷
• 期第7期
• 印刷ISSN0305-7372
• 文件大小245.11KB
• 发表时间2004-11
• DOI10.1016/s0305-7372(04)00144-6
• 页码655-659